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Abstract
Neurotropic herpesviruses can establish lifelong infection in humans and contribute to severe diseases including encephalitis 
and neurodegeneration. However, the mechanisms through which the brain’s immune system recognizes and controls viral 
infections propagating across synaptically linked neuronal circuits have remained unclear. Using a well-established model 
of alphaherpesvirus infection that reaches the brain exclusively via retrograde transsynaptic spread from the periphery, and 
in vivo two-photon imaging combined with high resolution microscopy, we show that microglia are recruited to and isolate 
infected neurons within hours. Selective elimination of microglia results in a marked increase in the spread of infection and 
egress of viral particles into the brain parenchyma, which are associated with diverse neurological symptoms. Microglia 
recruitment and clearance of infected cells require cell-autonomous P2Y12 signalling in microglia, triggered by nucleotides 
released from affected neurons. In turn, we identify microglia as key contributors to monocyte recruitment into the inflamed 
brain, which process is largely independent of P2Y12. P2Y12-positive microglia are also recruited to infected neurons in 
the human brain during viral encephalitis and both microglial responses and leukocyte numbers correlate with the severity 
of infection. Thus, our data identify a key role for microglial P2Y12 in defence against neurotropic viruses, whilst P2Y12-
independent actions of microglia may contribute to neuroinflammation by facilitating monocyte recruitment to the sites of 
infection.
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Introduction
Microglia are the main immunocompetent cell type of the 
brain that play a role in diverse physiological processes, 
including brain development, synaptic plasticity and mem-
ory. In turn, alterations in microglial function are linked 
with common brain diseases such as stroke, epilepsy, Alz-
heimer’s or Parkinson’s disease [3, 28, 47, 63]. But how 
microglial actions determine the fate of individual neurons 
remained largely unclear to date. Microglia are capable of 
removing synapses via complement-mediated manner [26, 
59] and eliminate injured neurons via recognising translo-
cated phosphatidylserine on the cell membrane [7]. Numer-
ous mediators including chemokines, metalloproteinases, 
growth factors, purinergic metabolites, alarmins or damage-
associated molecular patterns such as HMGB1, histones and 
DNA have been revealed as indicators of neuronal injury 
and triggers for microglial activation [9, 29, 30, 57, 58]. 
Among these, microglial P2Y12 receptor-mediated actions 
have been shown to facilitate the movement of microglial 
processes to sites of injury or ATP administration [14, 25], 
whilst constant microglial surveillance of the brain was 
found to be largely P2Y12-independent [39, 53]. However, 
whether microglial P2Y12 is involved in early recognition 
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and clearance of injured neurons independently of mediating 
generic microglial actions to tissue injury remained unclear.
One of the major difficulties in studying microglial 
responses to mediators released from stressed neurons 
in vivo is the immediate response of surveilling microglia 
to any noxious stimuli [46], which is an inherent confounder 
of most experimental models that include manipulation in 
the brain parenchyma. To overcome these difficulties, we 
took advantage of the genetically modified strains of pseu-
dorabies virus (PRV), a member of the subfamily Alphaher-
pesvirinae (similar to human herpes simplex virus type 1 
or varicella-zoster virus), widely used for neuroanatomical 
tract-tracing and as a well-established model of neurotropic 
virus infection [6, 8]. When injected into peripheral organs, 
the “Bartha-Dup” strains of PRV display slow and highly 
specific retrograde transsynaptic spread in central autonomic 
circuits [6], allowing us to study directed microglial recruit-
ment in parallel with the propagation of virus infection in 
the brain using in vivo imaging and advanced histological 
approaches. Since in this model microglia may only sense 
signals identifying affected neurons in their vicinity, but do 
not become infected with PRV even under ex vivo conditions 
unlike in the case of most viruses with potential or preferen-
tial neurotropism in vivo [6, 50], we could also investigate 
the functional role of microglia and microglial P2Y12 recep-
tors in the control of infection together with the associated 
neuroinflammatory response.
Although some previous papers have implicated micro-
glia in anti-viral immunity [11, 17, 40, 49, 50], most of them 
have not used selective microglia manipulation in vivo, and 
the potential mechanisms of early microglia recruitment 
including the role of microglial P2Y12 have not been inves-
tigated. We have shown earlier that microglia sense changes 
in neuronal activity and selective elimination of microglia 
by CSF1R-blockade leads to the dysregulation of neuronal 
network activity and augmented brain injury [56]. Since 
neurons infected with PRV-Bartha derivatives have normal 
electrophysiological characteristics but display increased 
activity [42], we hypothesised that microglia may detect 
detrimental changes in the case of individual cells before 
irreversible neuronal injury occurs. Using this model sys-
tem, we demonstrate the rapid and targeted recruitment of 
microglia to compromised neurons using in vivo two-photon 
and in vitro time-lapse imaging and show that nucleotides 
released from infected neurons mediate this effect via micro-
glial P2Y12 receptors. We show that through these actions, 
microglia are instrumental to prevent contact infection and 
control the transneuronal spread of neurotropic virus infec-
tion. Whilst demonstrating the role for P2Y12 in the elimina-
tion of infected cells by microglia in both the mouse and the 
human brain, we also show that microglia, but not micro-
glial P2Y12 contribute to the recruitment of monocytes to 
transsynaptically infected neurons during viral encephalitis. 
Since neurotropic herpesviruses are capable of causing both 
acute and chronic infection in humans and also contribute to 
diverse forms of neurodegeneration [38, 64], these results 
are likely to be relevant for a number of neuroinflammatory 
and neurodegenerative diseases.
Materials and methods
Mice
Experiments were carried out on 12–18  weeks old 
C57BL/6  J,  P2Y12−/−,  P2RX7−/−,  Cx3Cr1GFP/+ and 
 Cx3Cr1GFP/+  P2Y12−/− mice. All experimental procedures 
were in accordance with the guidelines set by the European 
Communities Council Directive (86/609 EEC) and the 
Hungarian Act of Animal Care and Experimentation (1998; 
XXVIII, Sect. 243/1998), approved by the Animal Care and 
Use Committee of the IEM HAS.
Selective elimination of microglia from the brain
Mice were fed PLX5622 (Plexxikon Inc. Berkeley, USA; 
1200 mg PLX5622 in 1 kg chow) for 3 weeks to eliminate 
microglia from the brain.
Neurotropic herpesvirus infection
Mice were randomly assigned to experimental groups and 
were injected either intraperitoneally or directly into the 
epididymal white adipose tissue with a genetically modi-
fied PRV-Bartha derivative, PRV-Bartha-Dup-Green (BDG) 
[5] to induce retrograde transsynaptic infection in the brain. 
In a set of studies, mice were infected with BDG on 16th 
day of PLX5622 diet to assess the effect of microglia deple-
tion on central propagation of virus infection. For in vivo 
two-photon imaging,  Cx3Cr1GFP/+ mice were infected with 
PRV-Bartha-DupDsRed (BDR) [4] enabling the co-detection 
of infected neurons with microglia. After virus injection, 
mice were let to survive for 5–7 days depending on study 
design and were regularly monitored for neurobehavioral 
symptoms.
Tissue processing and immunofluorescence
Brain tissues were fixed by transcardial perfusion (saline, 
followed by 4% PFA). Immunofluorescence was performed 
on 25 μm thick free-floating brain sections. Images were 
captured with a Nikon Ni-E C2 + confocal microscope.
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Super‑resolution (STORM) microscopy
Sections were mounted onto #1.5 thick borosilicate cover-
slips and covered with imaging medium [50] immediately 
before imaging. STORM imaging was performed for P2Y12 
(stimulated by a 647 nm laser) using a Nikon N-STORM 
C2 + super-resolution system that combines ‘Stochastic 
Optical Reconstruction Microscopy’ technology and Nikon’s 
Eclipse Ti research inverted microscope to reach a lateral 
resolution of 20 nm and axial resolution of 50 nm [1, 18].
Immuno‑electron microscopy
After the combined immunogold–immunoperoxidase stain-
ings, sections were treated with osmium tetroxide, dehy-
drated in ascending ethanol series and acetonitrile, and 
embedded in epoxy resin. During dehydration, sections were 
treated with uranyl acetate. After polymerization, 70 nm 
thick sections were cut on an ultramicrotome, picked up on 
formvar-coated single-slot copper grids, and sections were 
examined using a Hitachi H-7100 electron microscope.
Correlated confocal laser‑scanning microscopy, 
electron microscopy and electron tomography
Following multiple immunofluorescent staining, sections 
were analysed using a Nikon Eclipse Ti-E inverted micro-
scope, and an A1R laser confocal system. After imaging, 
sections were recovered and the immunoperoxidase reaction 
was developed. Electron tomography was performed using 
a Tecnai T12 BioTwin electron microscope equipped with 
a computer-controlled precision stage and an Eagle™ 2 k 
CCD 4 megapixel TEM CCD camera. Reconstruction was 
performed using the IMOD software package.
Post‑mortem human brain samples
To investigate microglia recruitment in response to neuro-
tropic virus infection in the human brain, paraffin-embedded 
(FFPE) post-mortem brain tissues from five patients with 
known HSV-encephalitis aged 42–66 years were analysed 
(ethical approval ETT-TUKEB 62031/2015/EKU, 34/2016 
and 31443/2011/EKU (518/PI/11)). Tissue samples from 
two additional patients with no known neurological disease 
were used as controls. After deparaffinisation, immunohis-
tochemistry was performed, and representative pictures were 
captured using a Nikon Ni-E C2 + microscope.
Two‑photon imaging
To assess microglia recruitment to infected neurons in the 
mouse brain in real-time,  Cx3CR1GFP/+ mice were i.p. 
injected with 10 μl of the BDR virus. The survival time was 
set to 7 days post-infection, when numerous infected cells 
were present in the cerebral cortex. After cranial window 
preparation, measurements were performed on a Femto2D-
DualScanhead microscope (Femtonics Ltd., Hungary) cou-
pled with a Chameleon Ultra II laser [10, 27]. Data acqui-
sition was performed by MES softver (Femtonics Ltd.), 
two-photon image sequences were exported from MES and 
analysed using ImageJ.
Primary neuronal, astroglia and microglia cell 
cultures
Primary cultures of embryonic cortical cells were prepared 
from mice on embryonic day 15 [12] and astroglia/microglia 
mixed cell cultures were prepared from the whole brains 
of mouse pups, as described earlier [32]. Microglial cells 
were isolated from 21 to 28 days old mixed cultures either 
by shaking or by mild trypsinization. In cultures used for 
time-lapse recordings, microglial cells were seeded on top 
of astrocytic or neuronal cell cultures in 10000 cell/cm2 
density. Neuronal or astroglia cultures were infected with 
either PRV-Bartha-Dup-Green (BDG) virus or PRV-Bar-
tha-DupLac (BDL) at a final titer of 2.5 × 105 PFU/ml, as 
described earlier [24]. The multiplicity of infection (MOI) 
was ~ 0,17 PFU/cell.
Time‑lapse microscopy and cell motility data 
analysis
Time-lapse recordings were performed on a computer-
controlled Leica DM IRB inverted fluorescent microscope. 
Phase contrast and epifluorescent images were collected 
consecutively every 10 min for up to 48 h post-infection. 
Images were edited using NIH ImageJ software. Cell track-
ing: images were analysed individually with the help of cus-
tom-made cell-tracking programs (G-track and Wintrack) 
enabling manual marking of individual cells and recording 
their position parameters into data files.
Cytokine measurement from media of primary cell 
cultures
Concentrations of IL-1α, IL-1β, TNF-α, IL-6, MCP-1, 
RANTES (CCL5), G-CSF and KC (CXCL1) were measured 
from conditioned media of primary neuronal, astroglial and 
microglial cell cultures using cytometric bead array (CBA) 
Flex Sets. Measurements were performed on a BD FACS-
Verse machine and data were analysed using an FCAP Array 
software (BD Biosciences) as described earlier [16]. The 
cytokine levels of conditional media were corrected for total 
protein concentrations of the samples measured by Bradford 
Protein Assay Kit.
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Total RNA isolation and quantitative RT‑PCR
For total RNA isolation, cell culture samples were homog-
enized in 500 μl TRI Reagent and isolation was performed 
using Tissue Total RNA Mini Kit according to the manu-
facturer’s instructions. The primers were used in real-time 
PCR reaction with Fast EvaGreen qPCR Master Mix on 
a StepOnePlus instrument. The gene expression was ana-
lysed using the StepOne 2.3 program. Amplicons were 
tested by Melt Curve Analysis on StepOnePlus instrument. 
Experiments were normalized to gapdh expression.
Quantification of nucleotides and adenosine
The adenine nucleotides (ATP, ADP, AMP) and adenosine 
(Ado) were determined in extracts from cells and culture 
media using HPLC method. The HPLC system used was a 
Shimadzu LC-20 AD Analytical & Measuring Instruments 
System, with an Agilent 1100 Series Variable Wavelength 
Detector set at 253 nm.
Immunohistochemical staining for NTPDase1
Coronal brain sections were incubated in the solution 
of the polyclonal NTPDase1 antibody. After secondary 
antibody incubation and chromogen development, sec-
tions were osmificated, dehydrated in ascending ethanol 
series, and embedded in Taab 812 resin. Ultrathin sections 
were examined using a Hitachi 7100 transmission electron 
microscope.
Enzyme histochemistry for detection of ecto‑ATPase 
activity
A cerium precipitation method was used for electron micro-
scopic investigation of ecto-ATPase activity [31]. The tissue 
blocks were then postfixed, dehydrated, treated and embed-
ded into Taab 812 resin for ultrathin sectioning and micro-
scopic examination.
Flow cytometric analysis of brain, spleen and blood 
samples
Cells were isolated from mouse brains by enzymatic diges-
tion with the mixture of DNase I and Collagenase/Dispase. 
Spleen cells were isolated by mechanical homogenization 
of the spleen. Venous blood was collected from the heart 
before transcardial perfusion using 3.8% sodium citrate as an 
anticoagulant. Cells were acquired on a BD FACSVerse flow 
cytometer and data were analysed using FACSuite software. 
Total blood cell counts were calculated using 15 μm poly-
styrene microbeads.
Statistical assessment
All quantitative measurements and analysis were performed 
in a blinded manner in accordance with STAIR and ARRIVE 
guidelines. Data were analysed using the GraphPad Prism 
7.0 software. For comparing two experimental groups Stu-
dent’s t test with Welch’s correction or Mann–Whitney U 
test, for comparing three or more groups one-way or two-
way ANOVA followed by Tukey’s, Sidak’s and Dunnett’s 
post hoc comparison was used. P < 0.05 was considered 
statistically significant.
Please refer to the Supplementary Methods (Online 
Resource 1) for additional details.
Results
Microglia are instrumental for anti‑viral immunity 
in the brain
To study whether microglia respond to local cues and are 
recruited to virus-infected neurons, we made use of the pre-
cisely controlled, retrograde transsynaptic spread of the PRV 
derivative, Bartha-DupGreen (BDG) to central autonomic 
nuclei [5, 6] from peripheral targets (Fig. 1a). In the hypo-
thalamic paraventricular nucleus (PVN), microglial num-
bers increased threefold in response to infection and infected 
neurons were surrounded by numerous Iba1-positive cells 
(Fig. 1b, c), 6 days after intraperitoneal (i.p.) virus injection. 
To investigate whether microglia are involved in the control 
of neurotropic virus infection, we performed selective deple-
tion of microglia, by feeding mice the CSF1R antagonist 
PLX5622, as demonstrated earlier [20, 56]. After 3 weeks 
of depletion, 96% of microglia were eliminated from the 
brain as evidenced by the lack of the microglial markers Iba1 
and P2Y12 (Fig. 1d, e). Selective elimination of microglia 
resulted in a marked increase in the number of virus-infected 
neurons in the brain (Fig. 1f–g). This phenomenon was not 
dependent on the route of virus administration, since after 
i.p. virus injection or injection of the virus into the epididy-
mal white adipose tissue (an organ receiving predominantly 
sympathetic innervation [2]), the number of virus-infected 
neurons was much higher in the brain in the absence of 
microglia [Fig. 1h; Suppl. Fig. 1 (Online Resource 1)]. In 
microglia-depleted mice, numerous infected cells were also 
present in the cerebral cortex already on day 5, and retro-
grade infection reaching the cortex was more widespread, 
affecting several areas normally not infected when microglia 
were present. In addition, more than a threefold increase in 
the number of disintegrated neurons containing viral proteins 
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Fig. 1  Selective elimination of microglia results in uncontrolled viral 
spread and neurobehavioral pathologies. a Retrograde transneuronal 
spread of PRV-Bartha-DupGreen (BDG) to the hypothalamic para-
ventricular nucleus (PVN) 6  days after intraperitoneal injection. b 
Focal neuronal infection induces recruitment of microglia (Iba1: yel-
low) to infected neurons (PRV: cyan) in the PVN. c Microglial num-
bers increase significantly at sites of virus-infected neurons, area: 
0.2 mm2. d Selective depletion of microglia by PLX5622 for 3 weeks 
(yellow: Iba-1, magenta: P2Y12). e Depletion results in the elimina-
tion of 96% of microglia from the PVN. f An absence of microglia 
results in profound increases in virus-infected neurons in the brain. 
Control and microglia-depleted mice were injected intraperito-
neally with BDG on the 16th day of the diet and allowed to survive 
for 5  days to induce transsynaptic spread of PRV to the hypothala-
mus. Note the numerous infected neurons outside the nucleus indi-
cating increases in non-synaptic (contact) infection in the absence of 
microglia. g The number of infected neurons in the PVN increases 
over twofold in microglia depleted mice 5  days after virus injec-
tion. h An absence of microglia leads to profound increases in the 
number of infected neurons in the PVN. i An absence of microglia 
leads to increased number of infected, disintegrated neurons in the 
PVN. j Superresolution microscopic analysis (STORM) reveals 
the colocalization of the phagosome marker, CD68 (dark blue), 
with neuronal debris containing viral structural proteins (PRV) 
inside recruited microglia. k An absence of microglia leads to mas-
sive increases in extracellular virus proteins around infected, dis-
integrated neurons. l–p Transmission electron microscopic (TEM) 
images showing infected neurons in microglia competent (l, m) and 
depleted (n–p) animals. l Microglial processes (yellow pseudocolor) 
are found tightly attached to the cell membrane of infected neuron 
(cyan pseudocolor), as identified by anti-PRV immunogold labelling 
(black grains). Black arrows indicate a disrupted neuronal membrane 
segment isolated by a microglial process. m Infected neuronal cell 
debris is phagocytosed by microglia. Note the presence of viral cap-
sids inside phagocytosed neuronal particles labelled with anti-PRV 
immunogold (insert). n In the absence of microglia disintegrated neu-
ronal membranes with anti-PRV-immunogold labelled content invad-
ing the surrounding neuropil can be seen (white arrows). o Infected 
neuron contains viral capsids (black arrowheads), asterisk marks the 
nucleus, mature virions with strong PRV-immunogold labelling can 
be seen in the cytoplasm (white arrowheads). p PRV-virions are dis-
played at higher magnification. q Absence of microglia results in 
rapidly appearing neurological symptoms 5 days after PRV infection 
(0: no symptoms, 1: drooling and heavy breathing, 2: seizures and 
muscle spasms). Data expressed as mean ± s.e.m c *p < 0.05 n = 4–5, 
Mann–Whitney test e ****p < 0.0001 n = 6 unpaired t test, h, i 
****p < 0.0001 Mann–Whitney test n = 10–11 i **p < 0.001 unpaired 
t test n = 9–12, q ****p < 0.0001 Mann–Whitney test n = 20–21 Scale 
bars: b 50 µm, d 50 µm, g, 100 µm, j–k 100 µm. Scale bar on m is 
400 nm for l–o, 175 nm for p 
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was found in the brain parenchyma in microglia-depleted 
mice (Fig. 1i), indicating the lack of effective elimination of 
the infected neurons by microglia. To investigate this phe-
nomenon further, we visualized viral proteins using super-
resolution microscopy together with the microglial phago-
some/lysosome marker CD68 (Fig. 1j, k). In control mice, 
microglial processes tightly surrounded the cell bodies of 
infected neurons with viral proteins appearing in microglial 
phagosomes (Fig. 1j). Importantly, the absence of microglia 
resulted in a massive increase in extracellular viral proteins 
and PRV-immunopositive cell debris (Fig. 1k). Confirming 
these observations, electron microscopy revealed a direct 
contact between microglial processes and the cell membrane 
of the infected neurons as well as the uptake of infected 
neurons by microglia (Fig. 1l, m). In contrast, disintegrated 
neuronal membranes and extracellular immunogold-labelled 
viral proteins were observed in microglia-depleted animals 
(Fig. 1n–p). BDG products, including GFP signal [5, 6], viral 
capsids and PRV-immunopositive profiles were not observed 
in the nucleus or the cytoplasm of microglia [Suppl. Fig. 2 
(Online Resource 1)], indicating that productive infection 
does not develop in these cells, in line with earlier reports [6, 
50]. The absence of microglia was also associated with the 
development of diverse neurological symptoms in infected 
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mice starting on the 5th day of infection, when infected neu-
rons were numerous in the brain stem, the hypothalamus 
and the autonomic-associated nuclei in the limbic system. 
These symptoms included heavy breathing, muscle spasms 
and seizure-like episodes, which were absent in control mice 
(Fig. 1q).
Microglia recruitment is initiated rapidly 
to virus‑infected neurons in the brain
Having confirmed the instrumental role of microglia in 
controlling neurotropic virus infection, we aimed to inves-
tigate whether the recruitment of microglia occurs early 
enough to allow the isolation of infected neurons prior to 
the breakdown of neuronal cell membranes. To this end, we 
made use of the immediate-early marker, GFP, expressed 
in infected neurons several hours prior to the production 
of viral structural proteins, which allows time-mapping 
the different phases of infection at a single neuron level 
[5, 6, 15]. GFP-positive neurons expressing low levels of 
viral structural proteins (Phase II cells) already appeared 
more surrounded by microglia than the majority of neurons 
expressing GFP only (Phase I, Fig. 2a, b), suggesting that 
recruitment of microglia is induced within a few hours of 
infection, by the time viral structural proteins are produced 
[5, 6, 15]. The number of microglia increased further around 
neurons expressing high levels of viral proteins (Phase III), 
resulting in 1–3 microglial cells contacting the cell body of 
a single, infected neuron (Fig. 2a, b).
To investigate the processes of microglia recruitment 
in vivo in real-time, we used another virus strain, PRV-Bar-
tha-DupDSRed (BDR), enabling early phases of infection 
to be identified based on the production of the red fluores-
cent protein, DSRed [4]. Mice with functional microglia 
were allowed a longer, 7 days survival after virus injection, 
resulting in the spread of infection to the upper layers of 
the cerebral cortex (Fig. 2c). In vivo two-photon imaging in 
 Cx3Cr1+/GFP (microglia reporter) mice revealed the recruit-
ment of microglia within 3 h of the increases observed in 
neuronal DSRed signal [Suppl. Video 1. (Online Resource 
2)]. We used an optimized cranial window preparation 
for these studies as developed earlier, to avoid any distur-
bance of microglia [56]. 3D reconstruction from 2P Z-stack 
revealed that microglial processes formed a barrier-like 
structure, with several contact points around the cell body of 
the infected neuron (Fig. 2d). Microglia recruited to infected 
cells showed increased process velocity compared to micro-
glia distant from sites of virus infection (Fig. 2e), indicat-
ing that microglia may respond to local signals induced by 
infected neurons. To further explore whether microglial 
contacts with the cell membranes of infected neurons can 
be formed in the early phases of virus infection, we visual-
ized microglia–neuron contacts with confocal microscopy in 
 Cx3Cr1+/GFP mice, followed by the investigation of selected 
neurons with correlated electron microscopy and electron 
tomography. 3D reconstruction from confocal Z-stack 
revealed the formation of microglial contacts around the cell 
body and the main dendrites of infected neurons [Fig. 2f; 
Suppl. Video 2. (Online Resource 3)] prior to the appear-
ance of mature virions in the neuronal cytoplasm (Fig. 2g, 
h). At this stage of infection, neuronal cell membranes were 
intact with normal chromatin structure seen in the nucleus 
[Suppl. Fig. 2b (Online Resource 1)]. Microglial processes 
surrounding infected neurons showed CD68-immunopositiv-
ity, indicating the phagocytic activity of microglia (Fig. 2f, 
g). In addition, electron tomography revealed the formation 
of specific membrane interactions between infected neurons 
Fig. 2  Microglia rapidly isolate virus-infected neurons in the brain. a 
Microglia (Iba1, yellow) are recruited to neurons infected with PRV 
expressing GFP with immediate-early kinetics (BDG) in the hypo-
thalamic paraventricular nucleus (PVN). Note that microglia recruit-
ment starts after the expression of the immediate-early marker GFP 
(phase I), when low levels of viral structural proteins become detect-
able (phase II). High levels of viral structural proteins indicate a late 
stage of viral infection (phase III), which is associated with higher 
number of microglia recruited to infected cells. b Microglial numbers 
increase significantly around virus-infected neurons in parallel with 
the propagation of infection c In  vivo two-photon imaging reveals 
the recruitment of microglia (green) to virus-infected neurons (red) 
in real-time. Retrograde transsynaptic infection was induced by the 
virus BDR in  Cx3Cr1+/GFP microglia reporter mice 7  days prior to 
imaging to visualize infected cells in the cerebral cortex based on the 
immediate-early DSRed expression. d Merged Z-planes of microglial 
cells around a PRV-DSRed-positive neuron (arrows indicate recruited 
microglia, arrowheads indicate microglial processes contacting the 
infected cell). e Microglial process velocity increases significantly 
in response to viral infection compared to that seen in control mice. 
f–i Correlated CLSM, electron microscopy and electron tomography 
confirms direct microglia–neuron contact with intercellular molecu-
lar links in early phase of viral infection. f, 3D-reconstruction from 
deconvolved confocal stack of a recruited microglia (green) engulfing 
a PRV-positive neuronal cell body (cyan) with CD68-positive phago-
lysosomes (magenta) within the microglia, arranged around infected 
neuron. Upper insert: single image plane of the same confocal stack. 
Middle insert: 3D-reconstruction of the same microglial cell, rotated 
180° around the vertical axis. Asterisk labels the bay engulfing the 
soma of the infected neuron. Lower insert: 3D-reconstruction of the 
infected neuronal cell body with surrounding phagolysosomes located 
within the microglia. g Transmission electron micrograph shows the 
same cells on an ultrathin section matching the confocal image plane 
in the upper insert in f. Note that microglial processes surround the 
apical dendrites of the infected neuron. h Part of g (in white box) 
enlarged. Note that the nucleus is void of viral capsids and the mem-
brane of the neuron is intact (white arrowheads), confirming the early 
phase of infection. i 3 nm thick electron tomographic section and cor-
responding 3D-reconstruction shows the very close cell–cell contact 
between the same microglia (green pseudocolor) and infected neuron 
(cyan pseudocolor, mitochondria are in yellow). White arrows point 
to putative contact sites, where the distance between the membranes 
is the smallest, and several filament-like structures (magenta) can be 
observed connecting the two cells. b ***p < 0.001 one-way ANOVA, 
n = 8; e *p < 0.05, unpaired t test, n = 10. Scale bars: a 10  µm; c 
20 µm; d 20 µm; f 2 µm; g 1 µm; h 400 nm; i 100 nm
◂
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and microglia suggesting the recognition and contact of the 
intact cell membranes by recruited microglial processes 
(Fig. 2i).
Virus‑infected cells are recognised and engulfed 
by microglia in vitro
To study the mechanisms of microglia recruitment to sites 
of infection, we first established co-cultures of neurons and 
GFP-positive microglia from  Cx3Cr1+/GFP mice and per-
formed time-lapse imaging over a 48 h period. Microglia 
contacted the cell body and the main processes of uninfected 
neurons without causing injury or showing phagocytic activ-
ity [Fig. 3a, upper and mid panel and Suppl. Videos 3, 4. 
(Online Resources 4, 5)]. In contrast, microglia added to 
virus-infected neurons were recruited to and phagocytosed 
infected cells [Fig. 3a, bottom panel and Suppl. Video 5. 
(Online Resource 6)]. Next, we aimed to study the behaviour 
Fig. 3  Virus infection triggers the recruitment and phagocytic activity 
of microglia in  vitro. a  Cx3Cr1+/gfp microglial cells (green) repeat-
edly interact with non-infected neuronal processes and cell bodies 
without hindering process outgrowth or affecting network stability. 
Red arrows point to an uninterruptedly growing neurite (upper panel 
and Supplementary Video 3.) or a microglia slipping under a dense 
neuronal network (mid panel and Supplementary Video 4.). Micro-
glial cells contacting PRV-infected neurons flatten and phagocytose 
compromised cells (blue arrow, bottom panel), also see Supplemen-
tary Video 5. b  Cx3Cr1+/gfp microglial cells (green) move freely in 
non-infected astroglial cultures making and releasing contacts with 
several astrocytes (upper panel and Supplementary Video 6.) while 
they are recruited to infected cells (bottom panel and Supplemen-
tary Video 7.) and after scanning they display phagocytic activity 
(blue arrow). Satellite images: PRV + particles (red), eaten up by a 
 Cx3Cr1+/gfp microglial cell (green). c Trajectories of randomly cho-
sen microglial cells (n = 52) over 24 h in control or infected astroglial 
cultures. Individual cell trajectories were centered to start from the 
origin and superimposed for better comparison of migration direc-
tionality. Insets show typical trajectories. Note the random walk 
behaviour in the trajectory in the upper inset (control), and the shorter 
trajectory with targeted directionality (arrow) characterizing the 
slower migrating and scanning microglial cells in infected cultures 
in the lower inset. d Time-dependent average velocities of micro-
glial cell populations in control (n = 54) or infected (n = 56) astroglial 
cultures. e Average velocities of microglial cells over 24  h are sig-
nificantly lower in infected astroglial cultures. f Frequency distribu-
tion of time-dependent average velocities of microglial populations 
in control or infected astroglial cultures. g Average displacement of 
microglial cells in various time intervals of migration in control or 
infected astroglial cultures. Error stripes correspond to s.e.m. Scale 
bars: a 10 µm; b 25 and 10 µm, respectively. Data are expressed as 
mean ± s.e.m. e n = 121, unpaired t test, ****p < 0.0001
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of microglia with more advanced statistical approaches [24, 
43, 44], which required co-cultures of microglia with very 
sparsely distributed cells. Since this was not feasible with 
neuronal cultures, we took advantage that astrocytes are also 
infected with PRV under in vitro conditions [24]. In fact, 
in sparse astrocyte cultures microglial cells migrated much 
longer distances on average to reach infected cells. Statisti-
cal analysis of longer cell trajectories thus enabled us to 
more effectively separate random migration from targeted 
migration of microglial cells to infected cells, followed by 
localized scanning activity and phagocytosis [Fig. 3b, upper 
panel and Suppl. Video 6. (Online Resource 7)].
As seen in neuronal cultures, microglia recognised and 
phagocytosed infected astrocytes, which was confirmed 
by immunofluorescent detection of the engulfed cells after 
imaging [Fig. 3b, bottom panel and insert, Suppl. Video 
7. (Online Resource 8)]. Statistical analysis revealed the 
recruitment of microglia to PRV-infected cells and the 
formation of prolonged cell-to-cell contacts. This was evi-
denced by microglia trajectories showing characteristic 
localized pattern as cells tend to remain at virus-infected 
cells once they met them (Fig. 3c), which is in sharp contrast 
with microglia trajectories in uninfected cultures showing a 
random walk behaviour pattern. This phenomenon was asso-
ciated with a reduction of cell velocities in infected cultures 
(16.6 ± 3.2 µm/h in control and 10.3 ± 2.6 µm/h in infected 
cultures, Fig. 3d–g) indicating that signals from infected 
cells direct microglial migration, scanning behaviour and 
subsequent phagocytic activity. Similar microglial responses 
were seen in neuronal/microglial co-cultures [Suppl. Fig. 3 
(Online Resource 1)]. Importantly, the development of pro-
ductive infection was never observed in microglia in vivo 
or in vitro even after the direct exposure of the cells to high 
viral titres or following extensive phagocytic activity, as 
evidenced by the absence of the immediate-early GFP sig-
nal and PRV proteins from microglia outside phagosomes 
[Suppl. Fig. 4 (Online Resource 1)].
Nucleotides released from infected cells trigger 
microglia recruitment and phagocytosis 
via microglial P2Y12
To investigate the production of inflammatory mediators 
induced by neurotropic virus infection, we measured sev-
eral inflammatory cytokines and chemokines that are com-
monly upregulated in response to virus infection [37] in cul-
tured neurons and astrocytes. Bacterial lipopolysaccharide 
(LPS), a widely used proinflammatory stimulus, induced a 
robust increase in TNFα, IL-6, CXCL1, CCL5 (RANTES), 
G-CSF and MCP-1 levels in astrocytes and CXCL1, CCL5 
and MCP-1 levels in neurons. In contrast, virus infection 
increased only CCL5 levels in both cell types at mRNA and 
peptide levels 24 h after infection [Suppl. Fig. 5 (Online 
Resource 1)], which did not explain the rapid recruitment 
of microglia to infected cells.
Since synthesis and release of chemokines could last for 
several hours and our in vivo data suggested rapid microglia 
recruitment to sites of virus infection, we checked whether 
purine nucleotides such as ATP that are chemotactic for 
microglia at a short time scale [14] could be released from 
compromised cells. We found that cultured neurons released 
ATP after virus infection, which was associated with 
reduced ATP, ADP, AMP and adenosine levels in cell lysates 
(Fig. 4a, b), within hours upon the expression of the imme-
diate-early marker, GFP, which precedes the expression of 
viral structural proteins required for productive infection [5, 
6, 15]. The changes in purinergic metabolites were asso-
ciated with increased ecto-ATPase levels in infected cells 
(Fig. 4c), but were not due to apoptosis or necrosis, since at 
the early stages of infection neurons expressing high levels 
of GFP showed no annexin V binding or uptake of propid-
ium iodide [Suppl. Fig. 6 (Online Resource 1)]. In addition, 
increased ecto-ATPase levels and NTDPase1 expression 
were found in microglia at sites of virus infection in the brain 
(Fig. 4d–f), indicating that microglia respond to changes 
in the levels of purine nucleotides [55]. To investigate the 
mechanisms mediating microglial responses to purine nucle-
otides released from infected cells, we assessed microglial 
responses in co-cultures of  P2X7−/− or  P2Y12−/− microglia 
and wild type astrocytes. Similarly to that seen in wild type 
microglia (Fig. 3c–g), motility of  P2X7−/− cells decreased 
when exposed to infected cells (Fig. 4g–j) and trajectories 
showed characteristic localized pattern due to frequent scan-
ning activity [Fig. 4k, Suppl. Video 8. (Online Resource 
9)], indicating that P2X7 deficiency does not prevent the 
recognition of virus-infected cells by microglia. In contrast, 
virus-exposed P2Y12-deficient microglia showed increased 
motility (Fig. 4l–o) with trajectories characteristic of random 
walk behaviour and lacking the localized pattern [Fig. 4p, 
Suppl. Video 9. (Online Resource 10)], suggesting that these 
cells are unable to display targeted recruitment in response 
to infection. Furthermore, wild type and  P2X7−/− micro-
glia showed a markedly increased phagocytic activity in 
infected cultures, which was fully abolished in P2Y12-defi-
cient microglia [Fig. 4q–s and Suppl. Videos 10–11 (Online 
Resources 11–12)]. Thus, P2Y12 is a key contributor to rec-
ognition of compromised cells by microglia and to micro-
glial phagocytosis of virus-infected cells in vitro.
Recruitment of microglia and elimination 
of virus‑infected neurons are mediated 
by microglial P2Y12 in vivo
Next, we investigated whether nucleotides released from 
compromised neurons are involved in the recruitment of 
microglia in vivo. We found that virtually all microglia 
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Fig. 4  Purinergic signaling mediates microglia recruitment and 
phagocytosis upon virus infection. a and b, HPLC analysis of ATP, 
ADP, AMP and adenosine levels in the supernatant (a) and in the 
cellular fraction (b) of control and virus-infected neuronal cultures. 
c Ecto-ATPase enzyme histochemistry and densitometric analy-
sis. The ecto-ATPase activity is significantly enhanced upon infec-
tion. d NTDPase1 expression of a microglial cell (red) in the PRV-
infected brain. Note that the  NTDPase1+ microglia is in contact with 
an apparently disintegrating neuron (blue). e NTDPase1 expressing 
Iba1 + microglial cells in control and infected mouse brains. f Den-
sitometric analysis of NTDPase1 expression in control and infected 
mouse brain slices. g and l Time-dependent average velocities of 
 P2X7−/− (nc = 67, ni = 74) or  P2Y12−/− (nc = 51, ni = 59) micro-
glial cell populations in control or infected astroglial cultures. Note 
the gradual decrease in population velocity of  P2X7−/− microglia in 
infected culture and the lack of such decrease in  P2Y12−/− micro-
glia in similar conditions. h and m Average velocities of  P2X7−/− or 
 P2Y12−/− microglial cells over 24 h in control or infected astroglial 
cultures, i and n Frequency distribution of time-dependent average 
velocities of  P2X7−/− or  P2Y12−/− microglial populations in con-
trol or infected astroglial cultures. j and o Average displacement of 
 P2X7−/− or  P2Y12−/− microglial cells in various time intervals of 
migration in control or infected astroglial cultures. Error stripes cor-
respond to s.e.m. k and p Trajectories of equal number (n = 50) of 
randomly chosen  P2X7−/− or  P2Y12−/− microglial cells over 24 h in 
control or infected astroglial cultures. Individual cell trajectories were 
centered to start from the origin and superimposed for better com-
parison of migration directionality. Insets show typical trajectories. 
Note the more localized migration pattern due to the scanning activ-
ity of  P2X7−/− microglia in infected conditions (red arrow) as com-
pared to random walk behaviour and the lack of such localization in 
the trajectories of  P2Y12−/− microglia in infected astroglial culture. q 
Phagocytic activity of wild type (WT),  P2X7−/− or  P2Y12−/− micro-
glia cells in astroglial cultures infected with BDG virus. Green col-
our indicates the virus initiated expression of GFP in infected cells. 
Red arrows point to the phagocytosed cells. Note, that  P2Y12−/− 
microglia is unable to incorporate the infected cell. r and s Percent-
age of phagocytic events by wild type vs.  P2X7−/− (r) or  P2Y12−/− 
(s) microglial cells in control and infected cultures. a, b n = 4 per 
group, unpaired t test, *p < 0.05; **p < 0.001 c n = 6, unpaired t test, 
***p ≤ 0.0001 f n = 7, unpaired t test, **p < 0.01. h and m n = 121, 
unpaired t test, ****p < 0.0001. r and s, n = 9 per group, one-way 
ANOVA, **p < 0.001; ***p < 0.0005, ****p < 0.0001, ns = not sig-
nificant. Scale bars: c 25  μm; d 5  μm; e 10  μm; q 10  μm data are 
expressed as mean ± s.e.m
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surrounding the cell body and the processes of infected 
neurons in either C57BL/6 or  Cx3Cr1+/GFP mice expressed 
P2Y12 receptors [Fig. 5a, Suppl. Fig. 7 (Online Resource 
1)]. STORM super-resolution microscopy, which allowed 
visualization of P2Y12 receptors at 20 nm lateral resolution 
showed that microglial P2Y12 receptor numbers increased 
over twofold in response to infection and P2Y12 clusters 
in microglial processes contacting infected neurons were 
localized around the membrane of the infected cell (Fig. 5b, 
c). To investigate the contribution of purinergic signalling 
to antiviral immunity in vivo, we induced virus infection 
in mice lacking P2X7 or P2Y12 receptors (Fig. 5d). Both 
receptors are abundant in microglia, whereas P2Y12 is a 
microglia-specific marker in the brain [55] [see also Supp. 
Fig. 7 (Online Resource 1)]. We found that an absence of 
P2Y12 resulted in > 50% reduction in the numbers of micro-
glia recruited to infected neurons in the PVN (Fig. 5f, h; 
p < 0.05), whereas a non-significant trend to reduction (by 
35%) was seen in  P2X7−/− mice (Fig. 5e, g). Similarly to 
that seen after selective elimination of microglia (Fig. 1g), 
Fig. 5  P2Y12 receptor mediates recruitment of microglia in response 
to virus infection in vivo. a P2Y12-positive microglia are recruited to 
virus-infected neurons in the mouse brain (paraventricular hypotha-
lamic nucleus is shown, maximum intensity projection from confocal 
Z stack of 30 steps, made with 0,50 µm step size). b STORM super-
resolution microscopy reveals P2Y12 receptors clustering at micro-
glial cell membranes contacting virus-infected neurons. Neurons are 
identified by GFP expression with immediate-early kinetics indicating 
early stages of PRV infection. c Based on STORM images, microglial 
P2Y12 localisation point numbers (NLP) are significantly increased 
at microglia–neuron contact sites, when microglia contacting infected 
neurons are compared with microglia contacting uninfected cells. d 
Fluorescent images showing the propagation of virus infection in the 
paraventricular nucleus of the hypothalamus in wild type,  P2X7−/− 
and  P2Y12−/− mice. Infected neurons in the late phase of PRV infec-
tion are revealed by immunostaining against viral structural proteins 
(cyan blue), and microglia are labelled with Iba1 (yellow) (Maxi-
mum Intensity Projection from confocal Z stack of 16 steps, made 
with 0.88 µm step size). e, f In P2Y12 −/− mice (n = 7) significantly 
less (p < 0.05) microglia are recruited to infected neurons compared 
to that seen in wild type (n = 6) and  P2X7−/− mice (n = 7), area: 
0.2  mm2. g, h Correspondingly, significantly higher numbers of 
infected neurons are seen in  P2Y12−/− mice compared to wild-type 
animals, whilst no significant difference is observed between  P2X7−/− 
and wild-type mice. area:0,2 mm2. i Absence of P2Y12 receptor did 
not result in any neurological symptoms 6  days after virus infec-
tion. 3 V - 3rd ventricle. Scale bars: a, 50 µm; b, 100 µm; d, 50 µm. 
All data expressed as mean ± s.e.m c  ***p < 0.0001 unpaired t test 
n = 7–13 cells e, g  N.S. not significant f **p < 0.01 Mann–Whitney 
test, n = 7 h *p < 0.05 n = 7 unpaired t test
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the number of infected neurons containing viral structural 
proteins increased over threefold in  P2Y12−/− mice (Fig. 5f, 
h), but no changes were seen in  P2X7−/− mice (Fig. 5e, g). 
Interestingly, clusters of microglia observed in the brain at 
sites of virus infection in  P2Y12−/− mice were located in the 
close vicinity of degenerated, PRV-immunopositive neurons, 
suggesting that P2Y12 deficiency markedly impairs micro-
glial responses to signals released from infected neurons and 
compromises phagocytic responses, but does not fully block 
microglial migration to already disintegrated cells.
Despite the markedly increased number of infected neu-
rons in  P2Y12−/− mice, no neurological symptoms have been 
observed (Fig. 5i), suggesting that the absence of microglia 
(Fig. 1q), but not of microglial P2Y12 alone, can cause the 
adverse neurological outcome in this model. To confirm this 
and to test for possible mechanisms underlying this differ-
ence, a new study was performed enabling a direct com-
parison of control,  P2Y12−/− and microglia-depleted mice 
after infection. In  P2Y12−/− mice there was deficient recruit-
ment of microglia to infected neurons. As earlier, both the 
absence of P2Y12 and microglia depletion caused marked 
elevations in the numbers of infected and disintegrated neu-
rons, but both these measures were elevated significantly 
more in the microglia-depleted animals (Fig. 6a–c). His-
tological analysis on cresyl violet-stained brain sections 
also demonstrated significantly increased neuronal injury/
loss in both  P2Y12−/− and microglia-depleted animals with 
highest levels seen after microglia depletion [Suppl Fig. 8 
(Online Resource 1)]. However, the neurological symp-
toms only emerged with microglia depletion (Fig. 6d). In 
contrast, levels of extracellular virus proteins were iden-
tical in  P2Y12−/− and microglia-depleted mice, while 
markedly increased compared to control mice (Fig. 6e, f). 
 P2Y12−/− microglia did show significantly lower levels of 
CD68-positive phagolysosomes compared to that seen in 
control animals (Fig. 6g, h), indicating the lack of normal 
phagocytic activity in the absence of P2Y12.
Microglia recruit leukocytes into the brain 
in response to virus infection independently 
of P2Y12‑mediated signalling
Since previous studies have shown that blood-borne cells 
are recruited to the brain after virus infection [15, 48], 
we wondered whether microglia and P2Y12-mediated 
actions are involved in neuroinflammatory and neurobe-
havioral changes in this model. As expected, numerous 
round-shaped or elongated leukocytes with high CD45 
immunopositivity were recruited to sites of virus infection 
(Fig. 7a). These were clearly discriminated from micro-
glia based on their higher CD45 expression, morphology, 
the absence of the microglia/macrophage marker Iba1 
from the majority of the cells and the complete absence 
of P2Y12, which is a microglia-specific marker in the 
brain [Fig. 7b, Suppl Fig. 7 (Online Resource 1)]. P2Y12 
is known to be expressed at high levels by microglia com-
pared to monocytes or monocyte-derived macrophages 
[45]. Surprisingly, selective elimination of microglia 
resulted in a profound reduction in CD45-positive leu-
kocytes at sites of virus infection (Fig. 7a, c), despite 
the increased number of infected neurons compared to 
that seen in control mice (Fig. 1g). This was not due to 
changes in peripheral leukocyte populations in response to 
PLX5622, since elimination of microglia by PLX5622 did 
not cause a significant reduction in circulating or splenic 
myeloid cell populations including monocytes, granulo-
cytes and macrophages, and did not affect numbers of T 
cells and B cells [Suppl. Figs. 9 and 10 (Online Resource 
1)], confirming our earlier results obtained by another 
CSF1R antagonist, PLX3397 [56]. Infiltrating leukocyte 
populations have also been characterized by flow cytom-
etry. The main population of CD45-positive cells recruited 
in response to virus infection were monocytes  (CD45high, 
 Cx3Cr1+,  CD11b+,  Ly6Chigh,  Ly6G− cells), which popu-
lation was markedly reduced in the absence of functional 
microglia (Fig. 7d–g). A non-significant trend to increased 
Fig. 6  The absence of P2Y12-positive microglia leads to increased 
neuronal infection, impaired phagocytosis and the accumulation of 
extracellular virus particles. a PRV immunofluorescence showing 
a marked increase in the number of infected (PRV-positive) neurons 
in  P2Y12−/− mice and after microglia depletion, compared to control 
animals. Note the lack of recruited Iba1 + microglia (yellow) to PRV-
positive neurons in  P2Y12−/− mice (inserts). b Numbers of infected 
(PRV +), disintegrated neurons in control,  P2Y12−/− and microglia-
depleted mice. c Total number of infected (PRV +) neurons is sig-
nificantly higher in  P2Y12−/− and microglia-depleted mice. d An 
absence of microglia, but not P2Y12-deficiency results in rapidly 
deteriorating neurological symptoms 5  days after PRV infection (0: 
no symptoms, 1: drooling and heavy breathing, 2: seizures and mus-
cle spasms). e STORM super-resolution microscopy reveals a marked 
increase in extracellular PRV proteins in both  P2Y12−/− and micro-
glia-depleted mice compared to wild type mice. f Quantitative assess-
ment of extracellular PRV proteins on STORM images. Number of 
extracellular PRV-positive localisation points (NLP) is shown in each 
group. g Images showing microglial phagolysosomes identified by 
CD68 immunofluorescence in control  Cx3Cr1+/gfp, and P2Y12-defi-
cient  (Cx3Cr1+/gfp x  P2Y12−/−) mice. h P2Y12-deficient microglia 
show a significant reduction of CD68-positive phagolysosomes com-
pared to wild-type microglia (CD68 immunofluorescent integrated 
density/GFP immunofluorescent integrated density within micro-
glial cell bodies, p = 0.0322, Mann–Whitney U test, n = 35 cells/16 
ROIs). Data on d expressed as median and interquartile range, oth-
erwise as mean ± s.e.m. b, c, d Mann–Whitney U test, n = 5–6. Scale 
bars: a 100  µm; e and g 2  µm. All data expressed as mean ± s.e.m 
b Control vs P2Y12 *p < 0.05; Control vs Depleted ****p < 0.0001; 
P2Y12 vs Depleted **p < 0.001, One-Way ANOVA c Control vs 
P2Y12 **p < 0.001; Control vs Depleted ****p < 0.0001; P2Y12 vs 
Depleted ****p < 0.0001 One-Way ANOVA d Control vs Depleted 
****p < 0.0001; P2Y12 vs Depleted ****p < 0.0001 One-Way 
ANOVA f Control vs Depleted **p  <   0.001; Control vs P2Y12 
***p < 0.0001 One-Way ANOVA
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CD8 T cells in the brain in response to infection was also 
observed, which was not influenced by microglia deple-
tion [Suppl. Fig. 11 (Online Resource 1)]. We also found 
that microglia exposed to PRV in vitro produced (CCL5) 
RANTES and MCP-1, whereas CCL5 and IL-1α were 
significantly reduced in hypothalamus homogenates of 
infected mice after microglia depletion [Suppl. Fig. 13 
(Online Resource 1)]. Importantly, exaggerated virus 
infection in the brain was associated with an increase in 
circulating granulocytes in microglia depleted mice, sug-
gesting that peripheral myeloid populations were capa-
ble of responding to virus infection, but their recruitment 
into the brain was inhibited by the absence of microglia 
[Suppl. Fig. 9 (Online Resource 1)]. Next, we investigated 
whether purinergic signalling through P2Y12 in microglia 
could contribute to leukocyte recruitment into the brain 
in response to virus infection. Importantly, no changes in 
the numbers of CD45-positive, blood-borne leukocytes 
were seen in  P2Y12−/− mice after infection and monocyte 
infiltration was not impaired [Fig. 7g, h; Suppl. Fig. 12a, 
c, (Online Resource 1)]. Thus, microglia appear to be key 
inducers of monocyte recruitment into the brain, but these 
processes are largely independent of microglial P2Y12-
mediated mechanisms that play a key role in controlling 
the spread of virus infection.
Recruitment of P2Y12‑positive microglia 
and leukocytes at sites of infection in the human 
brain during herpes simplex encephalitis
To investigate microglia recruitment and neuroinflam-
matory changes in the human brain, we analysed her-
pes simplex type 1 (HSV-1) encephalitis temporal lobe 
samples in which infection had been confirmed both by 
PCR and immunohistochemistry as reported earlier [13]. 
Processes of P2Y12-positive human microglial cells were 
extended to HSV-1-positive cells, and infected neurons 
were surrounded by activated microglial cells [Fig. 8a, 
Suppl. Table 1 (Online Resource 1)]. This has been con-
firmed with another specific microglial marker, Tmem119 
(Fig. 8b). Infected cells were contacted by 1–3 microglia 
(on average 1.5 microglia/HSV1 + cell, Fig. 8c). Groups 
of recruited, amoeboid cells showing CD68-immunopos-
itivity indicating phagocytic activity were also observed 
at sites of virus infection (Fig. 8d). Microglial cells were 
negative to HSV antigens suggesting that productive virus 
infection does not develop in these cells. Leukocytes iden-
tified by CD45-immunohistochemistry and Giemsa stain-
ing, whilst being P2Y12- and Tmem119-negative have 
been found at sites of virus infection in close vicinity of 
HSV-1-positive cells and microglia (Fig. 8e–g). A strong 
positive correlation between leukocyte numbers and HSV-
1-positive cells was also observed (Fig. 8h). Populations 
of CD15-positive myeloid cells, and in lower amount, 
scattered CD3-positive lymphocytes and CD20-positive 
B cells were identified at areas of HSV1 infection (Fig. 8i). 
In the absence of HSV1 infection, the vast majority of 
Iba1-positive microglia was found to be P2Y12 positive 
(96%) and numbers of Tmem119-positive and P2Y12-
positive microglia were similar in the brain parenchyma 
[Suppl. Fig. 14 (Online Resource 1)]. We found that mod-
erate HSV1 infection (less than 50 HSV1-positive cells/
mm2) was mostly associated with the activation of local 
microglia which were Tmem119- and P2Y12-positive. 
CD68-positive cells with either ramified or amoeboid 
morphology were also observed in these areas. At areas 
of advanced HSV1 infection (50–500 HSV1-positive cells/
mm2), numerous CD45-positive cells were observed in the 
brain parenchyma, which was associated with markedly 
increased numbers of CD68-positive-macrophages (likely 
to be of both microglial and blood-borne origin). In line 
with this, the number of ramified microglia, and the total 
number of P2Y12-positive or Tmem119-positive cells was 
reduced [Fig. 8j, k and Suppl. Fig. 15. (Online Resource 
1)]. Interestingly, similar reduction in microglial numbers 
was seen in mice at areas showing heavy virus load at 
the advanced stages of virus infection in the brain [Suppl. 
Fig. 16 (Online resource 1)].
Fig. 7  Microglia are instrumental for leukocyte recruitment into the 
brain in response to virus infection, which is independent of P2Y12-
mediated signaling. a Recruitment of CD45-positive leukocytes 
(orange) to the hypothalamic paraventricular nucleus (PVN) is seen 
around virus-infected neurons (cyan), which is markedly reduced by 
selective elimination of microglia b P2Y12 expression (magenta) 
discriminates microglia from blood-borne cells expressing high lev-
els of CD45 (orange), most of which are negative for the microglia/
macrophage marker Iba1 (cyan). c Leukocyte numbers are signifi-
cantly lower in microglia depleted animals, area: 0,2  mm2, d Flow 
cytometric dot plots showing that microglia  (Cx3Cr1high,  CD45low 
 Lyc6− cells, P8) can be well characterized and separated from infil-
trating monocytes  (Cx3Cr1+/int,  CD45high,  Ly6Chigh,  Ly6G− cells, P9), 
during viral infection in the brain. The almost complete absence of 
microglia is seen after selective microglia depletion (gates P4). In 
spite of the exaggerated virus infection in the absence of microglia, 
 CD45high blood-borne leukocytes (P9 gate), specifically monocytes 
 (CD45high,  Cx3Cr1+,  CD11b+,  Lyc6high cells, P5 gate) are profoundly 
reduced in the microglia depleted brains. e  Cx3Cr1+/gfp microglia are 
profoundly reduced in the brain after feeding mice the CSF1R inhibi-
tor PLX5622 for 3 weeks. f Monocyte numbers increase significantly 
in response to virus infection in the brain, which is markedly reduced 
in microglia depleted animals. g Immunofluorescence shows infiltrat-
ing CD45-positive leukocytes (orange) around virus-infected neurons 
(cyan) in the paraventricular nucleus. h Numbers of infiltrating leuko-
cytes (orange) in  P2Y12−/− mice are not significantly different from 
control animals, area: 0,2  mm2 All data expressed as mean ± s.e.m 
c, ****p < 0.0001 unpaired t test n = 12; e control vs depleted 
****p < 0.0001, control inf. vs depleted inf. ****p < 0.0001 One-Way 
ANOVA; f control vs control inf. **p < 0.001, control inf. vs depleted 
inf. **p < 0.001 One-Way ANOVA. h n.s. not significant Scale bar a, 
b, g, 50 µm
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Fig. 8  Microglia and leukocytes are recruited to infected neurons in 
the human brain. a Different stages of recruitment of P2Y12 + micro-
glia (arrows, visualized by DAB-Ni) are observed around herpes 
simplex-1 (HSV1)-infected cells (brown, visualized by NovaRED 
HRP substrate) in the human cerebral cortex. Processes of P2Y12-
positive microglia contact HSV-positive neurons (i–ii) and assem-
blies of microglial cells are seen around infected cells (iii). Groups 
of P2Y12-positive microglia displaying amoeboid, phagocytic mor-
phology in the absence of detectable HSV antigens are also found in 
infected areas (iv). b. Microglia labelled with Tmem119 (arrows) are 
recruited to HSV1-positive neurons (i) and engulf HSV-positive cells 
(ii). c Quantification showing the average number of Tmem119-pos-
itive or P2Y12-positive microglia contacting HSV1-positive cells. d 
CD68-positive brain macrophages (DAB-Ni) surround infected neu-
rons (NovaRED). e Viral infection is associated with the recruitment 
of leukocytes (arrowheads) visualized by Giemsa stain (i) and CD45 
immunostaining (ii) in the vicinity of microglia (arrows) labelled with 
P2Y12 (i) or Tmem119 (iii). CD68-positive macrophages in close 
association with blood vessels and parenchymal CD68-positive cells 
with microglial morphology suggest a mixed (blood-borne and res-
ident) origin of brain phagocytes (iv). f In areas of virus infection, 
neurons surrounded by P2Y12-positive microglia are associated with 
leukocytes (Giemsa, arrowhead) and g CD45-positive leukocytes are 
recruited to HSV1-positive cells. h Leukocyte numbers in infected 
brain areas show correlation with the number of virus-infected cells. 
p < 0.0001, linear regression, n = 64 FOV, from 5 patients. i CD15-
positive myeloid cells, and in lower amount, CD3-positive lym-
phocytes and CD20-positive B cells are observed at areas of HSV1 
infection. j Moderate HSV1 infection (less than 50 HSV + cells/
mm2) is associated with the presence of numerous Tmem119-posi-
tive, P2Y12-positive microglia, and CD68-positive microglia/mac-
rophages, whilst decreased numbers of Tmem119 and P2Y12-pos-
itive cells. In advanced HSV1 infection (50–500 HSV + cells/mm2), 
markedly increased numbers of CD68-positive brain macrophages are 
observed in the brain parenchyma. k Quantification of parenchymal 
microglia and CD68-positive brain macrophages in the case of mod-
erate and advanced HSV1 infection. bw—blood vessel. Scale bars: a, 
b, d, f, g, h, i—10  μm; e and j—50  μm. k *p < 0.05, **p < 0.001, 
***p < 0.0001
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Discussion
Here, we show that microglial P2Y12-mediated responses 
are essential for the recognition and effective elimination 
of compromised neurons after virus infection that reaches 
the brain exclusively via retrograde transsynaptic spread. 
Microglia recruitment occurs within a few hours in vivo 
and leads to the phagocytosis of infected cells. Marked 
increases in the number of disintegrated cells and leakage 
of viral antigens into the extracellular space are seen in 
the absence of functional microglia, which are associated 
with exaggerated infection and the development of neu-
rological symptoms. We also show that P2Y12 receptors 
are key drivers of microglial phagocytosis both in vivo 
and in vitro and that microglial P2Y12 is essential for 
appropriate responses to nucleotides released by infected 
neurons in the brain. Furthermore, we identify microglia 
as key inducers of monocyte recruitment into the brain in 
response to neurotropic virus infection and also demon-
strate the relevance of these findings in the human brain.
Signals mediating early recognition of injured cells and 
those inducing phagocytosis of synapses or neurons by 
microglia in the brain are poorly defined, and the mecha-
nisms of microglial decision-making regarding the fate of 
injured neurons are presently unclear. Microglia may sense 
changes in neuronal activity via altered extracellular ion 
gradients, CX3CL1-CX3CR1 or CD200-CD200R inter-
actions, purinergic signalling, pannexin-1 hemichannels 
and other mechanisms to shape synaptic connectivity and 
neuronal networks under both physiological or pathologi-
cal conditions [3, 28, 36, 53]. In addition, we and others 
have shown that ’danger signals’ from injured cells in the 
brain such as DNA, HMGB1, heat shock proteins or ATP 
act as potent activators of microglia and also contribute 
to the outcome in different brain pathologies [16, 21, 34, 
35]. However, due to the complexity of these signalling 
pathways and the immediate response of microglia to any 
tissue disturbance, it is difficult to dissect the mechanisms 
through which microglia recognize stressed neurons in 
most experimental models of brain injury.
To establish a model of neuronal injury in which micro-
glial responses to local signals can be studied within a 
realistic time frame and without in situ manipulation of 
the brain microenvironment, we have used genetically 
modified PRV-Bartha derivatives, which exhibit precisely 
controlled, retrograde transneuronal spread but do not 
infect microglia [6, 50]. In addition, these recombinant 
PRV strains allowed precise time-mapping of the spread 
of infection due to the expression of reporter proteins with 
different kinetics [4, 6]. At the same time, we could inves-
tigate the functional contribution of microglia to neuro-
tropic herpesvirus infection, which has not been previously 
investigated using selective elimination of microglia. 
Since immune surveillance by circulating immune cells is 
restricted in the brain parenchyma [52], early recognition 
of infection by microglia is likely to be critical to mount an 
appropriate immune response. The central inflammatory 
response induced by neurotropic herpesviruses includ-
ing microglial activation and recruitment of blood-borne 
immune cells has been previously characterized by excel-
lent earlier studies [19, 48, 50] and our former data has 
also shown that microglia surround infected neurons in 
the brain [15]. Recent reports highlighted the importance 
of central type I interferon responses against vesicular 
stomatitis virus and herpes simplex virus type 1 implicat-
ing microglia as a source of inflammatory mediators in 
anti-viral immunity in the brain [17, 49]. However, the 
kinetics and the mechanisms of microglia recruitment to 
infected cells have remained unexplored to date, similarly 
to the need for phagocytic activity by microglia to control 
the spread of infection. Our data obtained both in vivo in 
real time and in vitro shows that the rapid and precisely 
controlled migration of functional microglia is critical not 
only to limit the spread of infection in the brain, but timely 
elimination of infected neurons is essential to prevent con-
tact infection and to control the leakage of viral particles 
and antigens into the brain parenchyma. The rapidly wors-
ening neurological symptoms of mice in the absence of 
microglia, but not in P2Y12-deficient mice, may be due 
to both exaggerated infection and the lack of microglial 
factors that control neuronal activity in the injured brain 
[3, 38, 56], which should be investigated in further studies. 
Since the PRV Bartha-Dup strains show highly specific 
neurotropism in vivo [4–6] and we did not find any sign of 
hematogenous dissemination of infection or immunoposi-
tivity to viral antigens in the liver or the spleen even after 
PLX5622 treatment, a major role of peripheral immune 
mechanisms in the markedly increased spread of infection 
in microglia-depleted mice is unlikely.
Infected cells, including neurons and microglia were 
reported to sense HSV-1 via cytoplasmic DNA sensors, 
namely the adaptor protein stimulator of type I IFN genes 
(STING) [49]. However, the signals initiating microglia 
recruitment to infected neurons in the absence of microglial 
infection had remained unclear. Our in vivo and in vitro data 
suggest that soon after the development of productive infec-
tion, purinergic mediators released from neurons recruit the 
processes of uninfected microglia in their vicinity, followed 
by the displacement of the cells, leading to the formation of 
tight membrane–membrane interactions with the infected 
neurons. Since PRV infection alters neuronal activity [42], 
we hypothesised that the earliest signals from infected neu-
rons to microglia are more likely to include mediators regu-
lating rapid microglia–neuron interactions in vivo than de 
novo production of inflammatory chemokines. Specifically, 
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noxious stimuli in neurons can trigger a sustained increase 
of extracellular ATP, which results in microglial activation 
and recruitment within minutes to hours [14, 22]. In fact, our 
data shows that purine nucleotides released from affected 
neurons contribute to microglial process extension, cell 
migration to infected neurons and subsequent phagocytic 
activity via microglial P2Y12 receptors. ATP released from 
injured cells leads to the activation of P2-type and adeno-
sine receptors upon extracellular ATP catabolism by ecto-
nucleotidases [51]. In line with this, we observed increased 
ecto-ATPase levels and NTDPase1 activity in infected cells 
and microglia. ATP is a strong chemotactic signal for micro-
glia in vivo [14] and hydrolysis of ATP to ADP, which is the 
main ligand for P2Y12 takes place by ecto-nucleotidases 
within minutes [51, 55]. In turn, increased P2Y12 recep-
tor levels were found on microglial processes contacting 
infected neurons, as assessed by super-resolution micros-
copy. Since infected neurons at the stage of immediate-early 
reporter protein expression are viable and electrophysiologi-
cally active [42], these results also imply that microglia are 
well-equipped to identify injured neurons way earlier than 
the integrity of the cell membranes is compromised. Our 
ultrastructural analysis and in vitro data also confirm this, 
showing normal cell membrane integrity until late stages of 
virus infection. Thus, in spite that P2Y12 has been impli-
cated earlier in the recruitment of microglia to sites of tissue 
injury in the brain [14, 25], the present in vivo and in vitro 
studies have identified the cell-autonomous effect of P2Y12 
on microglia to rapidly recognize and eliminate infected 
neurons for the first time. We also show that P2X7, which 
plays a major role in microglial inflammatory responses and 
cytokine production [54] is dispensable for anti-viral immu-
nity in this experimental model.
We also identify microglia as key contributors to mono-
cyte recruitment to the brain during virus infection. Previ-
ous studies have implicated activated microglia in leukocyte 
recruitment into the brain upon virus infection, and showed 
that antibodies to CXCL10 and CCL2 (MCP-1) reduce 
the migration of murine splenocytes toward HSV-infected 
microglia in vitro [40, 41]. In our experimental model, elimi-
nation of microglia by CSF1R blockade was highly selec-
tive, as it did not have a significant impact on circulating 
and splenic leukocytes (including myeloid cell types), and 
infection-induced increases in circulating granulocytes was 
preserved in PLX5622-treated mice. In contrast, recruitment 
of monocytes to the brain was almost completely abolished 
in microglia depleted mice. In these studies, we made use of 
both CD45 and Cx3Cr1 as markers to reliably discriminate 
microglia  (CD45low,  Cx3Cr1high,  Ly6c− cells) from mono-
cytes  (CD45high,  Cx3Cr1+,  Ly6chigh cells) without the need 
of complex BM chimeric studies that inherently include 
changes in BBB function and may cause microglia activa-
tion [62]. Importantly, microglial P2Y12 was essential to 
mediate microglia recruitment and phagocytosis, but was 
dispensable for monocyte recruitment to the brain. These 
data suggest that other microglial chemotactic factors (such 
as MCP-1 or RANTES) could be responsible for driving 
leukocyte migration to sites of infection and injury in the 
brain, which should be investigated in further studies. Since 
monocyte recruitment in  P2Y12−/− mice was identical to 
that seen in control animals, but both an absence of micro-
glia and P2Y12 deficiency resulted in markedly enhanced 
spread of infection, blood-borne monocytes may not signifi-
cantly limit viral spread in the current experimental model. 
A similar conclusion was presented in a model of corona 
virus infection induced by direct injection of the virus into 
the brain, in spite that reduction of microglia numbers was 
associated with higher number of blood-borne macrophages 
in this study [61]. Histological characterization of post-mor-
tem samples from human HSV-1 encephalitis cases also sug-
gests that P2Y12-positive microglia isolate infected neurons, 
and a marked increase in leukocyte recruitment was also 
associated with severe infection.
Microglia depletion, but not P2Y12 deficiency leads 
to characteristic neurological symptoms in virus-infected 
mice. In line with this, microglia-depleted mice had 
higher numbers of infected/dying neurons than that seen 
in  P2Y12−/− mice, while the levels of extracellular virus 
proteins were not different, although significantly increased 
in both groups compared to control mice. Thus, the rap-
idly deteriorating neurological outcome seen in microglia-
depleted animals may be partially due to the markedly 
increased neuronal infection and to the absence of potentially 
neuroprotective microglial mediators, such as interleukin-10 
[23]. While our data show that P2Y12-dependent mecha-
nisms are instrumental to limit neurotropic virus infection in 
the brain, additional microglial receptors could also contrib-
ute to this process. Since  P2Y12−/− mice showed compara-
ble leukocyte infiltration to control animals, while microglia 
depletion markedly influenced leukocyte responses, a role 
for blood-borne cells in shaping neurobehavioral symptoms 
seen in this experimental model cannot be fully excluded.
The implications of these data for neurological dis-
eases are far-reaching. The findings that microglia con-
trol neurotropic virus infection via P2Y12 in mice and the 
recruitment of P2Y12-positive microglia to HSV-1 cells 
was observed in the human brain suggest that microglial 
P2Y12 could play in general an important role in anti-
viral immunity in the CNS (Fig. 9). Beyond infectious 
diseases caused by alphaherpesviruses such as PRV in 
swine or HSV-1 in humans, other viruses such as rabies, 
Zika virus, Alphaviruses, West-Nile virus, Epstein Barr 
virus, Influenza A viruses, and Enteroviruses can exhibit 
neurotropism and cause diverse neuropathologies in 
both humans and rodents [33, 38, 60]. In addition, the 
emerging role of neurotropic viruses in many forms of 
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neurodegeneration [33, 38, 64] and the common molecu-
lar fingerprints of cellular injury suggest that understand-
ing the mechanisms through which microglia control the 
elimination of injured neurons in the brain could facilitate 
the development of targeted therapies in several common 
brain diseases.
Acknowledgements Funding was provided by the “Momentum” Pro-
gram of the Hungarian Academy of Sciences LP2016-4/2016 (AD), 
ERC-CoG 724994 (AD), OTKA K109743, K116654, the Hungarian 
Brain Research Program KTIA_13_NAP-A-I, and 2017-1.2.1-NKP-
2017-00002. We thank the Cell Biology Center (Flow Cytometry Core 
Facility) at the Institute of Experimental Medicine of the Hungarian 
Academy of Sciences, Budapest, Hungary for their assistance. We 
are grateful for the Department of Pathology, Saint Borbála Hospi-
tal, Tatabánya, Hungary, and the Human Brain Research Laboratory, 
Institute of Experimental Medicine, Budapest, Hungary for providing 
post-mortem human brain tissue samples from patients with no known 
neurological disease. We also thank Tamás Vicsek at Department of 
Biological Physics, Eötvös University, Budapest, for his contribution 
to in vitro cell motility studies. We thank László Barna, Csaba Pongor 
and the NMC Imaging Center at the Institute of Experimental Medicine 
for providing experimental and technical support.
Author contributions AD and ZK designed research; RF, CS. CS, BO, 
NL, BM, KT, CW, VN, EM, MB, ÁK, SF and AD performed research. 
TH and GK provided human post mortem brain materials and served 
as clinical and neuropathological experts for the study. ZB generated 
and provided recombinant PRV strains. BG, BSz and EM measured/
analysed in vitro data. BLW contributed new reagents. BR and GSZ 
contributed to in vivo two-photon imaging studies. AD and ZK super-
vised the study. AD wrote the paper with input from all authors.
Compliance with ethical standards 
Conflict of interest BLW is an employee of Plexxikon. BR is the 
founder of Femtonics Kft. and a member of its scientific advisory 
board.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://creat iveco 
mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided you give appropriate 
credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made.
References
 1. Barna L, Dudok B, Miczan V, Horvath A, Laszlo ZI, Katona I 
(2016) Correlated confocal and super-resolution imaging by Viv-
idSTORM. Nat Protoc 11:163–183. https ://doi.org/10.1038/nprot 
.2016.002
 2. Bartness TJ, Liu Y, Shrestha YB, Ryu V (2014) Neural innerva-
tion of white adipose tissue and the control of lipolysis. Front 
Neuroendocrinol 35:473–493. https ://doi.org/10.1016/j.yfrne 
.2014.04.001
Fig. 9  Summary of neuroinflammatory changes after virus infection. 
In microglia-competent control mice, microglia recruitment around 
BDG-infected neurons is observed, which is associated with mono-
cyte recruitment at sites of infection. ATP released by compromised 
neurons may be cleaved by CD39 to ADP leading to stimulation of 
P2Y12 receptors and act as a trigger for microglia recruitment and 
phagocytosis. The lack of microglia leads to markedly increased 
numbers of viral infected neurons and an almost complete absence of 
monocyte recruitment. The lack of microglial P2Y12 leads to reduced 
microglial recruitment compared to control animals, suggesting the 
pivotal role of P2Y12 receptor in this process, whilst monocyte infil-
tration is comparable to that seen in control animals
 Acta Neuropathologica
1 3
 3. Bechade C, Cantaut-Belarif Y, Bessis A (2013) Microglial con-
trol of neuronal activity. Front Cell Neurosci 7:32. https ://doi.
org/10.3389/fncel .2013.00032 
 4. Boldogkoi Z, Balint K, Awatramani GB, Balya D, Busskamp V, 
Viney TJ, Lagali PS, Duebel J, Pasti E, Tombacz D et al (2009) 
Genetically timed, activity-sensor and rainbow transsynaptic viral 
tools. Nat Methods 6:127–130. https ://doi.org/10.1038/nmeth 
.1292
 5. Boldogkoi Z, Reichart A, Toth IE, Sik A, Erdelyi F, Medveczky 
I, Llorens-Cortes C, Palkovits M, Lenkei Z (2002) Construction 
of recombinant pseudorabies viruses optimized for labeling and 
neurochemical characterization of neural circuitry. Brain Res Mol 
Brain Res 109:105–118
 6. Boldogkoi Z, Sik A, Denes A, Reichart A, Toldi J, Gerendai I, 
Kovacs KJ, Palkovits M (2004) Novel tracing paradigms–geneti-
cally engineered herpesviruses as tools for mapping functional 
circuits within the CNS: present status and future prospects. 
Prog Neurobiol 72:417–445. https ://doi.org/10.1016/j.pneur 
obio.2004.03.010
 7. Brown GC, Neher JJ (2014) Microglial phagocytosis of live 
neurons. Nat Rev Neurosci 15:209–216. https ://doi.org/10.1038/
nrn37 10
 8. Card JP, Enquist LW (2014) Transneuronal circuit analysis with 
pseudorabies viruses. Curr Protoc Neurosci 68:151–239. https ://
doi.org/10.1002/04711 42301 .ns010 5s68
 9. Chen R, Kang R, Fan XG, Tang D (2014) Release and activ-
ity of histone in diseases. Cell Death Dis 5:e1370. https ://doi.
org/10.1038/cddis .2014.337
 10. Chiovini B, Turi GF, Katona G, Kaszas A, Palfi D, Maak P, Szalay 
G, Szabo MF, Szabo G, Szadai Z et al (2014) Dendritic spikes 
induce ripples in parvalbumin interneurons during hippocampal 
sharp waves. Neuron 82:908–924. https ://doi.org/10.1016/j.neuro 
n.2014.04.004
 11. Conrady CD, Zheng M, van Rooijen N, Drevets DA, Royer D, 
Alleman A, Carr DJ (2013) Microglia and a functional type I IFN 
pathway are required to counter HSV-1-driven brain lateral ven-
tricle enlargement and encephalitis. J Immunol 190:2807–2817. 
https ://doi.org/10.4049/jimmu nol.12032 65
 12. Czondor K, Ellwanger K, Fuchs YF, Lutz S, Gulyas M, Mansuy 
IM, Hausser A, Pfizenmaier K, Schlett K (2009) Protein kinase 
D controls the integrity of Golgi apparatus and the maintenance 
of dendritic arborization in hippocampal neurons. Mol Biol Cell 
20:2108–2120. https ://doi.org/10.1091/mbc.E08-09-0957
 13. Csonka T, Szepesi R, Bidiga L, Peter M, Klekner A, Hutoczky G, 
Csiba L, Mehes G, Hortobagyi T (2013) The diagnosis of herpes 
encephalitis–a case-based update. Ideggyogy Sz 66:337–342
 14. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, 
Littman DR, Dustin ML, Gan WB (2005) ATP mediates rapid 
microglial response to local brain injury in vivo. Nat Neurosci 
8:752–758. https ://doi.org/10.1038/nn147 2
 15. Denes A, Boldogkoi Z, Hornyak A, Palkovits M, Kovacs KJ 
(2006) Attenuated pseudorabies virus-evoked rapid innate 
immune response in the rat brain. J Neuroimmunol 180:88–103. 
https ://doi.org/10.1016/j.jneur oim.2006.07.008
 16. Denes A, Coutts G, Lenart N, Cruickshank SM, Pelegrin P, Skin-
ner J, Rothwell N, Allan SM, Brough D (2015) AIM2 and NLRC4 
inflammasomes contribute with ASC to acute brain injury inde-
pendently of NLRP3. Proc Natl Acad Sci U S A 112:4050–4055. 
https ://doi.org/10.1073/pnas.14190 90112 
 17. Drokhlyansky E, Goz Ayturk D, Soh TK, Chrenek R, O’Loughlin 
E, Madore C, Butovsky O, Cepko CL (2017) The brain paren-
chyma has a type I interferon response that can limit virus spread. 
Proc Natl Acad Sci U S A 114:E95–E104. https ://doi.org/10.1073/
pnas.16181 57114 
 18. Dudok B, Barna L, Ledri M, Szabo SI, Szabadits E, Pinter B, 
Woodhams SG, Henstridge CM, Balla GY, Nyilas R et al (2015) 
Cell-specific STORM super-resolution imaging reveals nanoscale 
organization of cannabinoid signaling. Nat Neurosci 18:75–86. 
https ://doi.org/10.1038/nn.3892
 19. Egan KP, Wu S, Wigdahl B, Jennings SR (2013) Immunological 
control of herpes simplex virus infections. J Neurovirol 19:328–
345. https ://doi.org/10.1007/s1336 5-013-0189-3
 20. Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg 
EE, Rice RA, Kitazawa M, Matusow B, Nguyen H, West BL 
et al (2014) Colony-stimulating factor 1 receptor signaling is 
necessary for microglia viability, unmasking a microglia pro-
genitor cell in the adult brain. Neuron 82:380–397. https ://doi.
org/10.1016/j.neuro n.2014.02.040
 21. Faraco G, Fossati S, Bianchi ME, Patrone M, Pedrazzi M, 
Sparatore B, Moroni F, Chiarugi A (2007) High mobility 
group box 1 protein is released by neural cells upon differ-
ent stresses and worsens ischemic neurodegeneration in vitro 
and in vivo. J Neurochem 103:590–603. https ://doi.org/10.111
1/j.1471-4159.2007.04788 .x
 22. Fields RD, Burnstock G (2006) Purinergic signalling in neu-
ron-glia interactions. Nat Rev Neurosci 7:423–436. https ://doi.
org/10.1038/nrn19 28
 23. Garcia JM, Stillings SA, Leclerc JL, Phillips H, Edwards NJ, 
Robicsek SA, Hoh BL, Blackburn S, Dore S (2017) Role of inter-
leukin-10 in acute brain injuries. Front Neurol 8:244. https ://doi.
org/10.3389/fneur .2017.00244 
 24. Gonci B, Nemeth V, Balogh E, Szabo B, Denes A, Kornyei Z, 
Vicsek T (2010) Viral epidemics in a cell culture: novel high 
resolution data and their interpretation by a percolation theory 
based model. PLoS ONE 5:e15571. https ://doi.org/10.1371/journ 
al.pone.00155 71
 25. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan 
WB, Julius D (2006) The P2Y12 receptor regulates microglial 
activation by extracellular nucleotides. Nat Neurosci 9:1512–
1519. https ://doi.org/10.1038/nn180 5
 26. Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ram-
akrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA et al 
(2016) Complement and microglia mediate early synapse loss 
in Alzheimer mouse models. Science 352:712–716. https ://doi.
org/10.1126/scien ce.aad83 73
 27. Katona G, Szalay G, Maak P, Kaszas A, Veress M, Hillier D, 
Chiovini B, Vizi ES, Roska B, Rozsa B (2012) Fast two-photon 
in vivo imaging with three-dimensional random-access scanning 
in large tissue volumes. Nat Methods 9:201–208. https ://doi.
org/10.1038/nmeth .1851
 28. Kettenmann H, Kirchhoff F, Verkhratsky A (2013) Microglia: 
new roles for the synaptic stripper. Neuron 77:10–18. https ://doi.
org/10.1016/j.neuro n.2012.12.023
 29. Kiernan EA, Smith SM, Mitchell GS, Watters JJ (2016) Mecha-
nisms of microglial activation in models of inflammation and 
hypoxia: implications for chronic intermittent hypoxia. J Physiol 
594:1563–1577. https ://doi.org/10.1113/JP271 502
 30. Kim JB, Sig Choi J, Yu YM, Nam K, Piao CS, Kim SW, Lee MH, 
Han PL, Park JS, Lee JK (2006) HMGB1, a novel cytokine-like 
mediator linking acute neuronal death and delayed neuroinflam-
mation in the postischemic brain. J Neurosci 26:6413–6421. https 
://doi.org/10.1523/JNEUR OSCI.3815-05.2006
 31. Kittel A (1999) Lipopolysaccharide treatment modifies pH- and 
cation-dependent ecto-ATPase activity of endothelial cells. J His-
tochem Cytochem 47:393–400. https ://doi.org/10.1177/00221 
55499 04700 313
 32. Kornyei Z, Szlavik V, Szabo B, Gocza E, Czirok A, Madarasz 
E (2005) Humoral and contact interactions in astroglia/stem 
cell co-cultures in the course of glia-induced neurogenesis. Glia 
49:430–444. https ://doi.org/10.1002/glia.20123 
Acta Neuropathologica 
1 3
 33. Koyuncu OO, Hogue IB, Enquist LW (2013) Virus infections in 
the nervous system. Cell Host Microbe 13:379–393. https ://doi.
org/10.1016/j.chom.2013.03.010
 34. Leak RK (2014) Heat shock proteins in neurodegenerative dis-
orders and aging. J Cell Commun Signal 8:293–310. https ://doi.
org/10.1007/s1207 9-014-0243-9
 35. Lenart N, Brough D, Denes A (2016) Inflammasomes link vascu-
lar disease with neuroinflammation and brain disorders. J Cereb 
Blood Flow Metab 36:1668–1685. https ://doi.org/10.1177/02716 
78X16 66204 3
 36. Li Y, Du XF, Liu CS, Wen ZL, Du JL (2012) Reciprocal regula-
tion between resting microglial dynamics and neuronal activity 
in vivo. Dev Cell 23:1189–1202. https ://doi.org/10.1016/j.devce 
l.2012.10.027
 37. Lokensgard JR, Cheeran MC, Hu S, Gekker G, Peterson PK (2002) 
Glial cell responses to herpesvirus infections: role in defense and 
immunopathogenesis. J Infect Dis 186(Suppl 2):S171–179. https 
://doi.org/10.1086/34427 2
 38. Ludlow M, Kortekaas J, Herden C, Hoffmann B, Tappe D, Trebst 
C, Griffin DE, Brindle HE, Solomon T, Brown AS et al (2016) 
Neurotropic virus infections as the cause of immediate and 
delayed neuropathology. Acta Neuropathol 131:159–184. https 
://doi.org/10.1007/s0040 1-015-1511-3
 39. Madry C, Kyrargyri V, Arancibia-Carcamo IL, Jolivet R, Kohsaka 
S, Bryan RM, Attwell D (2018) Microglial ramification, surveil-
lance, and interleukin-1beta release are regulated by the two-pore 
domain K(+) channel THIK-1. Neuron 97(299–312):e296. https 
://doi.org/10.1016/j.neuro n.2017.12.002
 40. Marques CP, Cheeran MC, Palmquist JM, Hu S, Urban SL, 
Lokensgard JR (2008) Prolonged microglial cell activation and 
lymphocyte infiltration following experimental herpes encepha-
litis. J Immunol 181:6417–6426
 41. Marques CP, Hu S, Sheng W, Lokensgard JR (2006) Microglial 
cells initiate vigorous yet non-protective immune responses 
during HSV-1 brain infection. Virus Res 121:1–10. https ://doi.
org/10.1016/j.virus res.2006.03.009
 42. McCarthy KM, Tank DW, Enquist LW (2009) Pseudorabies virus 
infection alters neuronal activity and connectivity in vitro. PLoS 
Pathog 5:e1000640. https ://doi.org/10.1371/journ al.ppat.10006 40
 43. Mehes E, Czirok A, Hegedus B, Szabo B, Vicsek T, Satz J, Camp-
bell K, Jancsik V (2005) Dystroglycan is involved in laminin-
1-stimulated motility of Muller glial cells: combined velocity and 
directionality analysis. Glia 49:492–500. https ://doi.org/10.1002/
glia.20135 
 44. Mehes E, Czirok A, Hegedus B, Vicsek T, Jancsik V (2002) 
Laminin-1 increases motility, path-searching, and process dyna-
mism of rat and mouse Muller glial cells in vitro: implication 
of relationship between cell behavior and formation of retinal 
morphology. Cell Motil Cytoskeleton 53:203–213. https ://doi.
org/10.1002/cm.10062 
 45. Moore CS, Ase AR, Kinsara A, Rao VT, Michell-Robinson M, 
Leong SY, Butovsky O, Ludwin SK, Seguela P, Bar-Or A et al 
(2015) P2Y12 expression and function in alternatively activated 
human microglia. Neurol Neuroimmunol Neuroinflamm 2:e80. 
https ://doi.org/10.1212/NXI.00000 00000 00008 0
 46. Ousman SS, Kubes P (2012) Immune surveillance in the cen-
tral nervous system. Nat Neurosci 15:1096–1101. https ://doi.
org/10.1038/nn.3161
 47. Prinz M, Priller J (2014) Microglia and brain macrophages in the 
molecular age: from origin to neuropsychiatric disease. Nat Rev 
Neurosci 15:300–312. https ://doi.org/10.1038/nrn37 22
 48. Rassnick S, Enquist LW, Sved AF, Card JP (1998) Pseudorabies 
virus-induced leukocyte trafficking into the rat central nervous 
system. J Virol 72:9181–9191
 49. Reinert LS, Lopusna K, Winther H, Sun C, Thomsen MK, Nanda-
kumar R, Mogensen TH, Meyer M, Vaegter C, Nyengaard JR 
et al (2016) Sensing of HSV-1 by the cGAS-STING pathway in 
microglia orchestrates antiviral defence in the CNS. Nat Commun 
7:13348. https ://doi.org/10.1038/ncomm s1334 8
 50. Rinaman L, Card JP, Enquist LW (1993) Spatiotemporal responses 
of astrocytes, ramified microglia, and brain macrophages to 
central neuronal infection with pseudorabies virus. J Neurosci 
13:685–702
 51. Rodrigues RJ, Tome AR, Cunha RA (2015) ATP as a multi-tar-
get danger signal in the brain. Front Neurosci 9:148. https ://doi.
org/10.3389/fnins .2015.00148 
 52. Russo MV, McGavern DB (2015) Immune surveillance of the 
CNS following infection and injury. Trends Immunol 36:637–650. 
https ://doi.org/10.1016/j.it.2015.08.002
 53. Sipe GO, Lowery RL, Tremblay ME, Kelly EA, Lamantia CE, 
Majewska AK (2016) Microglial P2Y12 is necessary for synaptic 
plasticity in mouse visual cortex. Nat Commun 7:10905. https ://
doi.org/10.1038/ncomm s1090 5
 54. Sperlagh B, Illes P (2014) P2X7 receptor: an emerging target in 
central nervous system diseases. Trends Pharmacol Sci 35:537–
547. https ://doi.org/10.1016/j.tips.2014.08.002
 55. Sperlagh B, Illes P (2007) Purinergic modulation of microglial cell 
activation. Purinergic Signal 3:117–127. https ://doi.org/10.1007/
s1130 2-006-9043-x
 56. Szalay G, Martinecz B, Lenart N, Kornyei Z, Orsolits B, Judak L, 
Csaszar E, Fekete R, West BL, Katona G et al (2016) Microglia 
protect against brain injury and their selective elimination dys-
regulates neuronal network activity after stroke. Nat Commun 
7:11499. https ://doi.org/10.1038/ncomm s1149 9
 57. Tsuda M (2016) Microglia in the spinal cord and neuropathic pain. 
J Diabetes Investig 7:17–26. https ://doi.org/10.1111/jdi.12379 
 58. Tsuda M, Inoue K (2016) Neuron-microglia interaction by 
purinergic signaling in neuropathic pain following neurodegen-
eration. Neuropharmacology 104:76–81. https ://doi.org/10.1016/j.
neuro pharm .2015.08.042
 59. Vasek MJ, Garber C, Dorsey D, Durrant DM, Bollman B, Soung 
A, Yu J, Perez-Torres C, Frouin A, Wilton DK et al (2016) A 
complement-microglial axis drives synapse loss during virus-
induced memory impairment. Nature 534:538–543. https ://doi.
org/10.1038/natur e1828 3
 60. Vermillion MS, Lei J, Shabi Y, Baxter VK, Crilly NP, McLane 
M, Griffin DE, Pekosz A, Klein SL, Burd I (2017) Intrauterine 
Zika virus infection of pregnant immunocompetent mice models 
transplacental transmission and adverse perinatal outcomes. Nat 
Commun 8:14575. https ://doi.org/10.1038/ncomm s1457 5
 61. Wheeler DL, Sariol A, Meyerholz DK, Perlman S (2018) Micro-
glia are required for protection against lethal coronavirus encepha-
litis in mice. J Clin Invest: https ://doi.org/10.1172/jci97 229
 62. Wilkinson FL, Sergijenko A, Langford-Smith KJ, Malinowska 
M, Wynn RF, Bigger BW (2013) Busulfan conditioning enhances 
engraftment of hematopoietic donor-derived cells in the brain 
compared with irradiation. Mol Ther 21:868–876. https ://doi.
org/10.1038/mt.2013.29
 63. Wu Y, Dissing-Olesen L, MacVicar BA, Stevens B (2015) 
Microglia: dynamic mediators of synapse development and plas-
ticity. Trends Immunol 36:605–613. https ://doi.org/10.1016/j.
it.2015.08.008
 64. Zhou L, Miranda-Saksena M, Saksena NK (2013) Viruses 
and neurodegeneration. Virol J 10:172. https ://doi.
org/10.1186/1743-422X-10-172
 Acta Neuropathologica
1 3
Affiliations
Rebeka Fekete1 · Csaba Cserép1 · Nikolett Lénárt1 · Krisztina Tóth1 · Barbara Orsolits1 · Bernadett Martinecz1 · 
Előd Méhes2 · Bálint Szabó2 · Valéria Németh2 · Balázs Gönci2 · Beáta Sperlágh3 · Zsolt Boldogkői4 · Ágnes Kittel3 · 
Mária Baranyi3 · Szilamér Ferenczi5 · Krisztina Kovács5 · Gergely Szalay6 · Balázs Rózsa6 · Connor Webb1 · 
Gabor G. Kovacs7,8 · Tibor Hortobágyi9,10,11 · Brian L. West12 · Zsuzsanna Környei1 · Ádám Dénes1 
1 “Momentum” Laboratory of Neuroimmunology, Institute 
of Experimental Medicine, Hungarian Academy of Sciences, 
Szigony u. 43, 1083 Budapest, Hungary
2 Department of Biological Physics, Eötvös University, 
Budapest, Hungary
3 Laboratory of Molecular Pharmacology, Institute 
of Experimental Medicine, Hungarian Academy of Sciences, 
Budapest, Hungary
4 Department of Medical Biology, Faculty of Medicine, 
University of Szeged, Szeged, Hungary
5 Laboratory of Molecular Neuroendocrinology, Institute 
of Experimental Medicine, Hungarian Academy of Sciences, 
Budapest, Hungary
6 Laboratory of 3D Functional Network and Dendritic 
Imaging, Institute of Experimental Medicine, Hungarian 
Academy of Sciences, Szigony u. 43, 1083 Budapest, 
Hungary
7 Institute of Neurology, Medical University of Vienna, 
Vienna, Austria
8 Neuropathology and Prion Disease Reference Center, 
Semmelweis University, Budapest, Hungary
9 MTA-DE Cerebrovascular and Neurodegenerative Research 
Group, University of Debrecen, Debrecen, Hungary
10 Institute of Psychiatry Psychology and Neuroscience, King’s 
College London, London, UK
11 Institute of Pathology, Faculty of Medicine, University 
of Szeged, Szeged, Hungary
12 Plexxikon Inc, Berkeley, CA 94710, USA
